$IRLA

IRulya Therapeutics Inc.

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New Haven, CT

IRLA chart

What traders are saying about $IRLA

Latest posts

IRulya Therapeutics Inc. news

IRulya Therapeutics Inc. key financials

USD2025202420232022
Net income-$84.0M-$56.8M-$31.4M-$51.7M
Diluted EPS$-1.68$-1.31$-0.84$-1.54
Total assets (year end)$93.5M$114.5M$167.9M$103.9M
Cash and equivalents (year end)$5.8M$6.2M–$40.6M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About IRulya Therapeutics Inc.

Ticker
IRLA (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
New Haven, CT
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1662774
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.

Frequently asked questions

What exchange is IRulya Therapeutics Inc. listed on?

IRulya Therapeutics Inc. trades on the Nasdaq under the ticker symbol IRLA.

What industry is IRulya Therapeutics Inc. in?

IRulya Therapeutics Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is IRulya Therapeutics Inc. headquartered?

IRulya Therapeutics Inc.'s business address on file with the SEC is in New Haven, CT.

When does IRulya Therapeutics Inc.'s fiscal year end?

IRulya Therapeutics Inc.'s fiscal year ends on December 31.